Advanced Filters
noise

Orbassano (To), Italy Clinical Trials

A listing of Orbassano (To), Italy clinical trials actively recruiting patients volunteers.

Found 64,783 clinical trials
F Fabio Tarantino, MD

The Italian Coronary Artery Aneurysm and Ectasia In Patients With Acute Coronary Syndrome

The ITACA study is a prospective, observational no profit registry enrolling patients with Acute Coronary Syndrome and angiographic evidence of coronary aneurysms and/or ectasia.

18 years of age All Phase N/A
M Michaela Trapl-Grundschober, MAS, MSc

Register Study: Implementation of Pharyngeal Electrostimulation Therapy for the Treatment of Acute Neurogenic Dysphagia

Neurogenic dysphagia occurs with disruption of neurological systems or processes involved in the execution of coordinated and safe swallowing. It is common in patients with neurological diseases, in particular in patients treated in Intensive Care Units (ICU) who are intubated (up to 62%) and / or tracheotomised (up to 83%). …

18 years of age All Phase N/A
F FABIO MARTELLI, PhD

Transcriptomic Study of Adult Population With Marfan Syndrome

This project is designed to discover circulating biomarkers for aortic aneurysms in adults affected by Marfan Syndrome (MFS). The first aim is to identify circulating transcripts, protein-coding (mRNA) and not (ncRNAs), which show differential expression between three groups of adult patients affected by MFS, based on: presence or absence of …

18 years of age All Phase N/A
C Carla Harenski

Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women

Substance use disorders and psychopathy are serious and costly mental health issues. Psychopathy is known to be associated with aberrant moral decision making and there is considerable interest in determining whether substance use disorders lead to impairments in these same cognitive processes. Recent large-scale research initiatives in forensic settings have …

18 - 70 years of age Female Phase N/A
S Sharon Tsuk

The Effect of Pharmacological Treatment for ADHD on Physical Performance in Male Adolescents

The aim of this study is to evaluate the effects of stimulant ADHD pharmacotherapy on motor performance in male adolescents.

15 - 18 years of age Male Phase N/A
M Michael Khalil, MD

Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis

By combining clinical, morphological and biochemical markers a better understanding of the formation and progression of multiple sclerosis (MS) should be obtained

18 - 85 years of age All Phase N/A
K Ka Hei Kenneth Lo, PhD

Feeding Mom Feeding Infant's Microbiota: Nutritional Strategies for Improving Breast Milk Composition and Infant Health

The first 1000 days, i.e., the earliest stage of life, is a unique period of opportunity to establish the foundations of human growth and health through the lifespan. In the recent decades, multiple studies have explored nutritional strategies for improving infant health through improving the nutritive and bioactive compositions in …

1 - 40 years of age All Phase N/A
I Isabelle RAYMOND, Pharm

Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia

The Internal Medicine Department of Haut-Lévêque Hospital (Pr E LAZARO, Pr JL PELLEGRIN, Pr JF VIALLARD) was accredited in 2017 by the Ministry of Health as a Constitutive Reference Center for Autoimmune Cytopenia. The investigators wish to launch new research projects in autoimmune cytopenia and propose a translational and fundamental …

18 years of age All Phase N/A
G Gregor Poglajen, MD, PhD

Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy

Although several studies have demonstrated beneficial effects of stem cell therapy in patients with non-ischemic dilated cardiomyopathy, the long term benefits and predictors of response to therapy remain undefined. The aim of this registry is to pool long-term clinical data in patients with non-ischemic dilated cardiomyopathy undergoing autologous cell therapy …

18 - 65 years of age All Phase N/A
c chengcheng Fu, PhD

A Study of NINLARO® in Chinese Adults With Multiple Myeloma

The main aim of this study is to check side effects and results in adults with multiple myeloma after switching from a bortezomib-based to an Ixazomib-based treatment. Treatment with NINLARO® will strictly follow the product label.

18 years of age All Phase N/A

Simplify language using AI